December 1st, 2011 by MuinKhouryMDPhD in Opinion, Research
No Comments »
In June 2011, the CDC Office of Public Health Genomics launched a community wide consultation process to develop priorities for the field of public health genomics in the next 5 years. This process was initiated as part of strategic visioning for integrating the emerging tools of genomics into practice and assuring the success of these new tools in improving population health. The process was conducted at a time of a widening gap between the rapid scientific advances in genomics and their impact on improving population health. The University of Michigan Center for Public Health and Community Genomics and Genetic Alliance spearheaded an effort to seek, collate and synthesize advice and recommendations from numerous stakeholders and constituents. The effort culminated in a workshop conducted on September 14, 2011 in Bethesda, Maryland. The results of the consultation, discussions and deliberations are summarized in a report published by the University of Michigan. Highlights of the recommendations are summarized here but readers should consult the full report. Some of the recommendations include:
To improve public health genomics education: Read more »
*This blog post was originally published at Genomics and Health Impact Blog*
December 1st, 2011 by John Mandrola, M.D. in Health Tips, Research
1 Comment »
There was important news this month on statin drugs. As one of the world’s most effective and commonly used medications, statins provide great writing topics. Lots of people have high cholesterol–including cyclists. Lots of people are interested in avoiding our mostly deadly disease.
I’d like to tell you about a recently-published (Lancet) landmark study that should quell safety concerns over statin drugs.
The punch line after I tell you the study’s results are short and sweet. Scroll down if you wish. But first, statin drugs are misunderstood enough to warrant a little blog-like simplicity. Let’s start with some background.
A brief statin review:
Statin drugs are best known for their cholesterol-lowering properties. The notion is simple: Read more »
*This blog post was originally published at Dr John M*
December 1st, 2011 by ErikDavis in Opinion, Research
No Comments »
I have skeptical confession to make. I was once a panacea-seeking antioxidant-taker. As background, I’m a marathon runner and occasional triathlete. Several years ago, I was training for an Ironman triathlon, and banking 20+ hours of intense exercise per week. That may sound absurd to many (it does to me, now that I have kids) but that kind of training is necessary for the long races. So what did this pharmacist-wannabe-triathlete with access to discount vitamins do? He stocked up on the fancy bottles of multivitamins, the “endurance” version, of course — with extra antioxidants. Why did I supplement? I wanted to maximize my workouts, speed recovery, and minimize downtime and the risk of injury. Oxidation sounds bad — like a rusting car. Anti-oxidants sounded like the ultimate in preventative medicine. My workouts may have been more extreme, but the practice of supplementing if you exercise is common among athletes.
As it turns out, not only were the antioxidants likely ineffective, they may have compromised some of the gains I was seeking with all that training. That I didn’t evaluate the evidence at the time was my critical-thinking blind spot. Over the the past several years, more data on antioxidants and exercise have emerged. A recent review article, Read more »
*This blog post was originally published at Skeptic North*
November 30th, 2011 by StevenWilkinsMPH in Opinion
1 Comment »
I may not know how to tell the difference between an empowered patient, an engaged patient, or an activated patient. But I do know that the fastest way to disempower, disengage, and de-activate any patient is a trip to the doctor’s office or the hospital. A visit to an average primary care physician (or specialist) is to an empowered/activated/engaged patient what Kryptonite is to Superman. It will stop all but the strongest willed patients dead in their tracks.
We patients have been socialized that way. Think about your earliest memories of “going to the doctor.” For me, I remember my Mom taking me to the Pediatrician. Early on I learned by watching the interaction between my Mom and the doctor that they each had a role. The doctor’s role was that of expert – he spoke and my Mom listened. I was there just to have one or more extremities twisted and prodded. And oh the medicinal smell…
Things haven’t changed much in the 40 years since I was a kid sitting in Dr. Adam’s office. Read more »
*This blog post was originally published at Mind The Gap*
November 30th, 2011 by DavidHarlow in Health Policy, Opinion
No Comments »
Harvard Pilgrim Health Care is re-launching Let’s Talk Health Care, which started life as former CEO Charlie Baker’s blog. There’s a series of related discussions going on now in the Let’s Talk Health Care Linked In group, sponsored by Harvard Pilgrim. I’ve been participating (at the request of the group organizer; disclosure: client) and would like to invite you to do the same.
A salient characteristic of the site and of the group is the focus on three broad categories of care and cost: fostering health and wellness, balancing quality and cost, and redefining care coordination — all of which are informed by a focus on chronic health care issues.
One of the great successes of modern medicine is the conquest of most infectious disease. (Equitable global distribution of the tools necessary for eradication is another story — and some of the more compelling chapters of that story are being told these days by The Bill and Melinda Gates Foundation.) One of the great failures of the modern consumer state is Read more »
*This blog post was originally published at HealthBlawg :: David Harlow's Health Care Law Blog*
In June 2011, the CDC Office of Public Health Genomics launched a community wide consultation process to develop priorities for the field of public health genomics in the next 5 years. This process was initiated as part of strategic visioning for integrating the emerging tools of genomics into practice and assuring the success of these new tools in improving population health. The process was conducted at a time of a widening gap between the rapid scientific advances in genomics and their impact on improving population health. The University of Michigan Center for Public Health and Community Genomics and Genetic Alliance spearheaded an effort to seek, collate and synthesize advice and recommendations from numerous stakeholders and constituents. The effort culminated in a workshop conducted on September 14, 2011 in Bethesda, Maryland. The results of the consultation, discussions and deliberations are summarized in a report published by the University of Michigan. Highlights of the recommendations are summarized here but readers should consult the full report. Some of the recommendations include:
